ACMS #34, June 2021

The 34th meeting of the Advisory Committee on Medicines Scheduling (ACMS #34), June 2021.

Date

22 June 2021

A meeting of the Advisory Committee on Medicines Scheduling (ACMS).

Members

The committee members are professionals with specific scientific, medical or clinical expertise, or expertise in consumer health issues relating to medicines.

Pre-meeting notices

For the pre-meeting public consultation notices go to:

Consultation: Proposed amendments to the Poisons Standard - ACMS #34, June 2021.
Consultation: Proposed amendments to the Poisons Standard (oral contraceptives) - ACMS #34, June 2021.
Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, June 2022.

Outcomes

Public submissions on interim decisions referred to the ACMS #34, ACCS #31 and Joint ACMS-ACCS #28 meetings held in June 2021

4 January 2023

Scheduling submissions

Public submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in June 2021
Notice of final decisions to amend (or not amend) the current Poisons Standard - ACMS #34, Joint ACMS-ACCS #28, ACCS #31

20 December 2021

Scheduling decisions (final)

Final decisions on proposed amendments to the Poisons Standard.
Public submissions on scheduling matters referred to the ACMS #34 meeting held in June 2021

15 December 2021

Scheduling submissions

Public submissions made in response to the public consultation on proposed amendments to the Poisons Standard - June 2021 ACMS meeting

Topics

Meeting of

Advisory Committee on Medicines Scheduling (ACMS)

Sub menu

ACMS #34, June 2021

Members

Pre-meeting notices

Outcomes

Public submissions on interim decisions referred to the ACMS #34, ACCS #31 and Joint ACMS-ACCS #28 meetings held in June 2021

Notice of final decisions to amend (or not amend) the current Poisons Standard - ACMS #34, Joint ACMS-ACCS #28, ACCS #31

Public submissions on scheduling matters referred to the ACMS #34 meeting held in June 2021

Related content

GMP Forum 2024

Help us improve the Therapeutic Goods Administration site